His primary scientific interests are in Internal medicine, Transplantation, Surgery, Bone marrow and Histocompatibility. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Oncology. The Transplantation study combines topics in areas such as Leukemia, Immunology and Human leukocyte antigen.
John P. Klein works mostly in the field of Surgery, limiting it down to topics relating to Relative risk and, in certain cases, Severity of illness and Complication. The various areas that John P. Klein examines in his Bone marrow study include Mortality rate and Risk factor. He interconnects International Prognostic Scoring System, Myelodysplastic syndromes and Proportional hazards model in the investigation of issues within Survival analysis.
His primary areas of study are Transplantation, Internal medicine, Surgery, Statistics and Immunology. His Transplantation research is multidisciplinary, incorporating perspectives in Survival rate, Human leukocyte antigen and Bone marrow. His studies in Internal medicine integrate themes in fields like Gastroenterology, Oncology and Histocompatibility.
John P. Klein combines topics linked to Anemia with his work on Surgery. His biological study deals with issues like Econometrics, which deal with fields such as Estimator, Competing risks, Parametric statistics, Censoring and Monte Carlo method. His research in Immunology intersects with topics in Donor selection and Haplotype, KIR Ligand.
John P. Klein focuses on Transplantation, Internal medicine, Immunology, Oncology and Surgery. His Transplantation research includes elements of Hematopoietic cell, Leukemia, Hematology and Survival analysis. John P. Klein has included themes like Econometrics and Cumulative incidence in his Survival analysis study.
His work in the fields of Human leukocyte antigen, Histocompatibility and Antibody overlaps with other areas such as Interferon beta-1a. His work carried out in the field of Oncology brings together such families of science as Group sequential, Chronic gvhd, Survival data and Lymphoma. His Surgery research incorporates elements of Anemia, Saline and Flushing.
John P. Klein spends much of his time researching Transplantation, Internal medicine, Immunology, Surgery and Human leukocyte antigen. In Transplantation, John P. Klein works on issues like Leukemia, which are connected to Myelodysplastic syndromes. His research in the fields of Survival analysis, Graft-versus-host disease and Total body irradiation overlaps with other disciplines such as Captopril and Placebo.
His research investigates the connection between Immunology and topics such as Oncology that intersect with problems in Peripheral T-cell lymphoma, Follicular lymphoma and Lymphoma. The concepts of his Surgery study are interwoven with issues in Body mass index, Hemoglobin, Obesity, Weight loss and Anemia. The Umbilical Cord Blood Transplantation research John P. Klein does as part of his general Human leukocyte antigen study is frequently linked to other disciplines of science, such as Locus and HLA-DP Antigen, therefore creating a link between diverse domains of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Survival Analysis: Techniques for Censored and Truncated Data
John P. Klein;Melvin L. Moeschberger.
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.
Stephanie J. Lee;John Klein;Michael Haagenson;Lee Ann Baxter-Lowe.
Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
Vanderson Rocha;John E. Wagner;Kathleen A. Sobocinski;John P. Klein.
The New England Journal of Medicine (2000)
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study
Mary Eapen;Pablo Rubinstein;Mei Jie Zhang;Cladd Stevens.
The Lancet (2007)
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
G Socié;J V Stone;J R Wingard;D Weisdorf.
The New England Journal of Medicine (1999)
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome
Corey S. Cutler;Stephanie J. Lee;Peter Greenberg;H. Joachim Deeg.
Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen
Peter J. Tutschka;Edward A. Copelan;John P. Klein.
IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE
Rowlings Pa;Przepiorka D;Klein Jp;Gale Rp.
British Journal of Haematology (1997)
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation
Richard E. Champlin;Norbert Schmitz;Mary M. Horowitz;Bernard Chapuis.
Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
Sarah Cooley;Daniel J. Weisdorf;Lisbeth A. Guethlein;John P. Klein.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: